Feng Chi Biotech Corp. (TPEX:6744)

Feng Chi Biotech Revenue

Feng Chi Biotech had revenue of 96.04M TWD in the half year ending June 30, 2025, with 1.79% growth. This brings the company's revenue in the last twelve months to 179.94M, up 3.76% year-over-year. In the year 2024, Feng Chi Biotech had annual revenue of 171.10M, down -5.25%.

• Revenue (ttm): 179.94M
• Revenue Growth: +3.76%
• P/S Ratio: 1.50
• Revenue / Employee: n/a
• Employees: 32
• Market Cap: 269.50M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	171.10M	-9.48M	-5.25%
Dec 31, 2023	180.58M	-12.88M	-6.66%
Dec 31, 2022	193.46M	10.89M	5.96%
Dec 31, 2021	182.57M	3.66M	2.05%
Dec 31, 2020	178.91M	4.58M	2.63%